Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 1994 Feb 15;298(Pt 1):115–119. doi: 10.1042/bj2980115

Vitamin E enhances the acylation of 1-O-alkyl-sn-glycero-3-phosphocholine in human endothelial cells.

K Tran 1, A F D'Angelo 1, P C Choy 1, A C Chan 1
PMCID: PMC1137990  PMID: 8129709

Abstract

1-O-Alkyl-2-acyl-sn-glycero-3-phosphocholine (alkylacyl-GPC) is the precursor of platelet-activating factor. It is formed via the CoA-independent transacylase reaction, which transfers the polyenoyl acyl group from the sn-2 position of a diacyl phospholipid to the sn-2 position of 1-O-alkyl-sn-glycero-3-phosphocholine (alkyl-GPC). We have reported previously that vitamin E alters phospholipid turnover in the endothelial cells by increasing arachidonic acid release and prostacyclin synthesis. In the present study, the role of vitamin E in the formation of alkylacyl-GPC was investigated. Incubation of endothelial cells with vitamin E resulted in an increase in the formation of [3H]alkylacyl-GPC from [3H]alkyl-GPC. The effect of vitamin E was dose-dependent at concentrations below 23 microM. However, vitamin E did not have a direct effect on the transacylase activity. When endothelial cells were incubated with vitamin E, the CoA-independent transacylase activity in the cell homogenate was found to be enhanced. Kinetic analysis of the transacylase activity in the pre-incubated cells showed that the enhancement of enzyme activity was at the enzyme-substrate level. When endothelial cells were incubated with vitamin E analogues (Trolox, tocol and tocopherol acetate), only limited enhancement of the transacylation process was detected. It is clear that vitamin E enhanced the synthesis of alkylacyl-GPC from alkyl-GPC in a very specific manner by an indirect stimulation of the CoA-independent transacylase activity. The regulation by vitamin E of the formation of alkylacyl-GPC may mediate the transfer of arachidonate from the diacyl phospholipid pool into the ether-linked phospholipid pool.

Full text

PDF
116

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert D. H., Snyder F. Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine by rat alveolar macrophages. Phospholipase A2 and acetyltransferase activities during phagocytosis and ionophore stimulation. J Biol Chem. 1983 Jan 10;258(1):97–102. [PubMed] [Google Scholar]
  2. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  3. Blank M. L., Spector A. A., Kaduce T. L., Lee T. C., Snyder F. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells. Biochim Biophys Acta. 1986 May 21;876(3):373–378. doi: 10.1016/0005-2760(86)90022-6. [DOI] [PubMed] [Google Scholar]
  4. Boogaerts M. A., Van de Broeck J., Deckmyn H., Roelant C., Vermylen J., Verwilghen R. L. Protective effect of vitamin E on immune triggered, granulocyte mediated endothelial injury. Thromb Haemost. 1984 Feb 28;51(1):89–92. [PubMed] [Google Scholar]
  5. Chan A. C., Tran K. The uptake of (R,R,R)alpha-tocopherol by human endothelial cells in culture. Lipids. 1990 Jan;25(1):17–21. doi: 10.1007/BF02562422. [DOI] [PubMed] [Google Scholar]
  6. Chao W., Siafaka-Kapadai A., Hanahan D. J., Olson M. S. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells. Biochem J. 1989 Jul 1;261(1):77–81. doi: 10.1042/bj2610077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chilton F. H., Connell T. R. 1-ether-linked phosphoglycerides. Major endogenous sources of arachidonate in the human neutrophil. J Biol Chem. 1988 Apr 15;263(11):5260–5265. [PubMed] [Google Scholar]
  8. Chilton F. H., Ellis J. M., Olson S. C., Wykle R. L. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. J Biol Chem. 1984 Oct 10;259(19):12014–12019. [PubMed] [Google Scholar]
  9. Chilton F. H., Murphy R. C. Remodeling of arachidonate-containing phosphoglycerides within the human neutrophil. J Biol Chem. 1986 Jun 15;261(17):7771–7777. [PubMed] [Google Scholar]
  10. Chilton F. H., O'Flaherty J. T., Ellis J. M., Swendsen C. L., Wykle R. L. Selective acylation of lyso platelet activating factor by arachidonate in human neutrophils. J Biol Chem. 1983 Jun 25;258(12):7268–7271. [PubMed] [Google Scholar]
  11. Chilton F. H. Potential phospholipid source(s) of arachidonate used for the synthesis of leukotrienes by the human neutrophil. Biochem J. 1989 Mar 1;258(2):327–333. doi: 10.1042/bj2580327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Garcia M. C., Mueller H. W., Rosenthal M. D. C20 polyunsaturated fatty acids and phorbol myristate acetate enhance agonist-stimulated synthesis of 1-radyl-2-acetyl-sn-glycero-3-phosphocholine in vascular endothelial cells. Biochim Biophys Acta. 1991 Apr 24;1083(1):37–45. doi: 10.1016/0005-2760(91)90122-x. [DOI] [PubMed] [Google Scholar]
  13. Kramer R. M., Deykin D. Arachidonoyl transacylase in human platelets. Coenzyme A-independent transfer of arachidonate from phosphatidylcholine to lysoplasmenylethanolamine. J Biol Chem. 1983 Nov 25;258(22):13806–13811. [PubMed] [Google Scholar]
  14. Kramer R. M., Patton G. M., Pritzker C. R., Deykin D. Metabolism of platelet-activating factor in human platelets. Transacylase-mediated synthesis of 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. J Biol Chem. 1984 Nov 10;259(21):13316–13320. [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Malone B., Lee T., Snyder F. Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product. J Biol Chem. 1985 Feb 10;260(3):1531–1534. [PubMed] [Google Scholar]
  17. Masuzawa Y., Sugiura T., Sprecher H., Waku K. Selective acyl transfer in the reacylation of brain glycerophospholipids. Comparison of three acylation systems for 1-alk-1'-enylglycero-3-phosphoethanolamine, 1-acylglycero-3-phosphoethanolamine and 1-acylglycero-3-phosphocholine in rat brain microsomes. Biochim Biophys Acta. 1989 Sep 11;1005(1):1–12. doi: 10.1016/0005-2760(89)90024-6. [DOI] [PubMed] [Google Scholar]
  18. McKean M. L., Smith J. B., Silver M. J. Phospholipid biosynthesis in human platelets. Formation of phosphatidylcholine from 1-acyl lysophosphatidylcholine by acyl-CoA:1-acyl-sn-glycero-3-phosphocholine acyltransferase. J Biol Chem. 1982 Oct 10;257(19):11278–11283. [PubMed] [Google Scholar]
  19. Robinson M., Blank M. L., Snyder F. Acylation of lysophospholipids by rabbit alveolar macrophages. Specificities of CoA-dependent and CoA-independent reactions. J Biol Chem. 1985 Jul 5;260(13):7889–7895. [PubMed] [Google Scholar]
  20. Suga K., Kawasaki T., Blank M. L., Snyder F. An arachidonoyl (polyenoic)-specific phospholipase A2 activity regulates the synthesis of platelet-activating factor in granulocytic HL-60 cells. J Biol Chem. 1990 Jul 25;265(21):12363–12371. [PubMed] [Google Scholar]
  21. Takamura H., Kasai H., Arita H., Kito M. Phospholipid molecular species in human umbilical artery and vein endothelial cells. J Lipid Res. 1990 Apr;31(4):709–717. [PubMed] [Google Scholar]
  22. Tan E. L., Snyder F. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by capillary endothelial cells isolated from rat epididymal adipose tissue. Thromb Res. 1985 Jun 15;38(6):713–717. doi: 10.1016/0049-3848(85)90215-4. [DOI] [PubMed] [Google Scholar]
  23. Tran K., Chan A. C. Effect of vitamin E enrichment on arachidonic acid release and cellular phospholipids in cultured human endothelial cells. Biochim Biophys Acta. 1988 Dec 16;963(3):468–475. doi: 10.1016/0005-2760(88)90315-3. [DOI] [PubMed] [Google Scholar]
  24. Tran K., Chan A. C. R,R,R-alpha-tocopherol potentiates prostacyclin release in human endothelial cells. Evidence for structural specificity of the tocopherol molecule. Biochim Biophys Acta. 1990 Apr 2;1043(2):189–197. doi: 10.1016/0005-2760(90)90295-9. [DOI] [PubMed] [Google Scholar]
  25. Weltzien H. U. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta. 1979 Aug 20;559(2-3):259–287. doi: 10.1016/0304-4157(79)90004-2. [DOI] [PubMed] [Google Scholar]
  26. Whatley R. E., Clay K. L., Chilton F. H., Triggiani M., Zimmerman G. A., McIntyre T. M., Prescott S. M. Relative amounts of 1-O-alkyl- and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in stimulated endothelial cells. Prostaglandins. 1992 Jan;43(1):21–29. doi: 10.1016/0090-6980(92)90061-w. [DOI] [PubMed] [Google Scholar]
  27. Winkler J. D., Sung C. M., Bennett C. F., Chilton F. H. Characterization of CoA-independent transacylase activity in U937 cells. Biochim Biophys Acta. 1991 Feb 5;1081(3):339–346. doi: 10.1016/0005-2760(91)90291-o. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES